Kentucky Retirement Systems Regeneron Pharmaceuticals, Inc. Transaction History

Kentucky Retirement Systems

$3.42 Billion
Q2 2024

A detailed history of Kentucky Retirement Systems transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Kentucky Retirement Systems holds 7,993 shares of REGN stock, worth $8.4 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

7,993

Previous 8,023 0.37%

Holding current value

$8.4 Million

Previous $7.72 Million 8.78%

% of portfolio

0.25%

Previous 0.23%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$883.2 - $1071.19 $26,496 - $32,135	-30 Reduced 0.37%	7,993 $8.4 Million
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $494,674 - $544,355	-548 Reduced 6.39%	8,023 $7.72 Million
Q4 2023 Feb 08, 2024	BUY	$775.18 - $881.7 $65,890 - $74,944	85 Added 1.0%	8,571 $7.53 Million
Q3 2023 Oct 12, 2023	SELL	$692.45 - $844.37 $130,873 - $159,585	-189 Reduced 2.18%	8,486 $6.98 Million
Q2 2023 Aug 07, 2023	BUY	$700.03 - $830.35 $122,505 - $145,311	175 Added 2.06%	8,675 $6.23 Million
Q1 2023 May 10, 2023	BUY	$680.49 - $826.97 $49,675 - $60,368	73 Added 0.87%	8,500 $6.98 Million
Q4 2022 Feb 06, 2023	BUY	$705.89 - $766.39 $25,412 - $27,590	36 Added 0.43%	8,427 $6.08 Million
Q3 2022 Nov 16, 2022	BUY	$573.97 - $724.32 $214,090 - $270,171	373 Added 4.65%	8,391 $5.78 Million
Q2 2022 Aug 08, 2022	BUY	$548.35 - $738.84 $666,793 - $898,429	1,216 Added 17.88%	8,018 $4.74 Million
Q1 2022 May 09, 2022	SELL	$595.12 - $698.43 $55,941 - $65,652	-94 Reduced 1.36%	6,802 $4.75 Million
Q4 2021 Feb 04, 2022	BUY	$543.48 - $670.97 $428,262 - $528,724	788 Added 12.9%	6,896 $4.36 Million
Q3 2021 Nov 17, 2021	BUY	$574.03 - $680.96 $6,314 - $7,490	11 Added 0.18%	6,108 $3.7 Million
Q2 2021 Aug 12, 2021	SELL	$472.8 - $558.54 $69,974 - $82,663	-148 Reduced 2.37%	6,097 $3.41 Million
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $33,504 - $41,115	-75 Reduced 1.19%	6,245 $2.96 Million
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $112,878 - $143,483	236 Added 3.88%	6,320 $3.05 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $255,487 - $308,700	469 Added 8.35%	6,084 $3.41 Million
Q2 2020 Aug 12, 2020	BUY	$493.32 - $643.92 $78,437 - $102,383	159 Added 2.91%	5,615 $3.5 Million
Q1 2020 May 01, 2020	BUY	$336.18 - $494.43 $452,498 - $665,502	1,346 Added 32.75%	5,456 $2.66 Million
Q4 2019 Feb 18, 2020	BUY	$274.13 - $376.51 $4,111 - $5,647	15 Added 0.37%	4,110 $1.54 Million
Q3 2019 Nov 05, 2019	BUY	$273.46 - $318.39 $118,408 - $137,862	433 Added 11.82%	4,095 $1.14 Million
Q2 2019 Aug 07, 2019	BUY	$299.6 - $414.82 $70,406 - $97,482	235 Added 6.86%	3,662 $1.15 Million
Q1 2019 May 22, 2019	BUY	$372.08 - $439.57 $18,976 - $22,418	51 Added 1.51%	3,427 $1.41 Million
Q4 2018 Feb 25, 2019	BUY	$335.82 - $403.04 $25,522 - $30,631	76 Added 2.3%	3,376 $1.26 Million
Q3 2018 Nov 19, 2018	SELL	$351.14 - $408.51 $1.12 Million - $1.3 Million	-3,184 Reduced 49.11%	3,300 $0
Q3 2018 Nov 16, 2018	BUY	$351.14 - $408.51 $1.12 Million - $1.31 Million	3,200 Added 97.44%	6,484 $0
Q2 2018 Aug 13, 2018	SELL	$284.6 - $344.99 $212,311 - $257,362	-746 Reduced 18.51%	3,284 $1.13 Million
Q1 2018 May 07, 2018	SELL	$315.82 - $393.78 $227,706 - $283,915	-721 Reduced 15.18%	4,030 $1.39 Million
Q4 2017 Feb 13, 2018	BUY	$358.63 - $469.95 $25,821 - $33,836	72 Added 1.54%	4,751 $1.79 Million
Q3 2017 Nov 08, 2017	SELL	$431.38 - $504.0 $88,864 - $103,824	-206 Reduced 4.22%	4,679 $2.09 Million
Q2 2017 Aug 18, 2017	BUY	N/A	4,885	4,885 $2.4 Million

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kentucky Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Kentucky Retirement Systems with notifications on news.

Account

Kentucky Retirement Systems Regeneron Pharmaceuticals, Inc. Transaction History